Related Experiment Video
Updated: Jun 2, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
CYberinfrastructure for COmparative effectiveness REsearch (CYCORE): improving data from cancer clinical trials
Translational Behavioral Medicine
|April 26, 2011
Summary
This study introduces the Cyberinfrastructure for Comparative Effectiveness Research (CYCORE) project to improve cancer research. CYCORE aims to enhance data integration and analysis for better cancer treatment decisions and outcomes.
Area of Science:
- Oncology
- Health Informatics
- Biomedical Research
Background:
- Comparative Effectiveness Research (CER) in oncology faces challenges due to lagging evidence synthesis and data integration.
- Limitations include poor patient adherence, difficulty measuring environmental influences, and understanding lifestyle behaviors affecting cancer progression.
- A 2009 report highlighted the limited focus on health behavior-change interventions as a major hindrance in CER.
Purpose of the Study:
- To describe an initiative aimed at improving CER in oncology by addressing existing limitations.
- To introduce the Cyberinfrastructure for Comparative Effectiveness Research (CYCORE) project.
- To develop a user-friendly, open-source cyberinfrastructure (CI) for cancer-related CER.
Main Methods:
- The CYCORE project is developing a CI prototype based on the National Science Foundation's "Cyberinfrastructure Vision for 21st Century Discovery" report.
- The CI will support the acquisition, storage, visualization, analysis, and sharing of data crucial for cancer CER.
- Requirements gathering for CYCORE has involved collaboration with cancer researchers.
Main Results:
- The development process for CYCORE has revealed novel ways CI design can enhance data collection and analysis for diverse data types.
- New partnerships have been formed among cancer researchers focused on advancing health-related CI.
- While still under development, the initiative shows promise for improving cancer CER.
Conclusions:
- The CYCORE project offers a potential solution to improve CER in oncology by enhancing data integration and accessibility.
- Effective CI design can significantly improve the collection and analysis of various data types in cancer research.
- This initiative fosters collaboration and advances the field of health-related cyberinfrastructure, ultimately benefiting cancer patients and clinicians.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...